Israel’s MeMed (see here previously) successfully completed the first clinical trial of its BV test to differentiate between bacterial and viral infections. The test on 260 patients with suspected lower respiratory tract infection resulted in a 62% relative reduction in … Continue reading →

Israel’s MeMed (see here previously) has been awarded nearly $727,800 from the US Biomedical Advanced Research and Development Authority (BARDA) to support a trial of its 15-minute MeMed BV test that distinguishes between bacterial and viral infections. https://www.me-med.com/press_release/memed-awarded-us-barda-contract/

The US FDA has approved the upgraded 15-minute bacteria vs virus diagnostic blood test device from Israel’s MeMed (see here previously). The new MeMed BV is now suitable for urgent care centers, as it avoids the clotting and spinning process … Continue reading →

The 15-min BV test from Israel’s MeMed (see here previously) accurately diagnosed over 90% of bacterial versus viral infections at Israel’s Schneider Children’s Medical Center, reducing Emergency Department physician error. The study tested 287 children from 3 months to 18 … Continue reading →

Arizona’s Tucson ER & Hospital has adopted the bacteria vs virus test from Israel’s MeMed (see here previously). The test distinguishes viral from bacterial infection within 15 minutes and avoids wasting antibiotics on a virus. https://www.me-med.com/press-releases/tucson-er-hospital-adopts-trailblazing-memed-bv-test/

Israel’s MeMed (see here previously) has been named as one of the “Fierce MedTech Fierce 15” most promising medical technology companies. The annual list is produced by the prestigious medical magazine and resource Fierce Biotech. https://www.me-med.com/_files/ugd/6a0f21_298b9f7e9e074852a576b8bf12773912.pdf https://www.fiercebiotech.com/special-reports/fierce-medtechs-2021-fierce-15

An international study, led by Ben Gurion University Professor Iris Shai, has shown that the green Mediterranean (MED) diet modifies the bacterial population in the gut. These changes in the microbiome can bring substantial health benefits, including reduced cardiac risk. … Continue reading →

Israel’s MeMed Diagnostics (see here previously) has received US FDA clearance for its MeMed BV blood test that can distinguish, in minutes, between bacterial and viral infections. It can help prevent the inappropriate use of antibiotics that leads to antimicrobial … Continue reading →

Israel’s MeMed (see here previously) has received Europe’s CE mark for its Covid-19 Severity disease management solution. The 15-min test measures proteins from serum samples and applies machine learning to identify patients likely to suffer a severe form of coronavirus … Continue reading →